Senescence of Pre-Osteoclasts in Non-Traumatic OA
非创伤性骨关节炎中前破骨细胞的衰老
基本信息
- 批准号:10326804
- 负责人:
- 金额:$ 35.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-01-15 至 2025-12-31
- 项目状态:未结题
- 来源:
- 关键词:AffectAgeAgingAngiogenic FactorAnkleApoptosisAttenuatedBlood VesselsBone MarrowBone Marrow CellsBone TissueCartilageCell AgingCell Cycle ArrestCell ProliferationCellsChronicChronic DiseaseClinical ResearchDegenerative polyarthritisDeteriorationDevelopmentDiagnosticDiseaseElderlyEnrollmentFrail ElderlyFunctional disorderGenesGeneticGoalsHand OsteoarthritisHigh Fat DietHip OsteoarthritisHumanJointsKnee OsteoarthritisKnee jointMeasuresMechanicsMetabolicMetabolic syndromeMononuclearMusMusculoskeletal DiseasesObesityOsteoclastsOsteogenesisPathogenesisPathogenicityPatientsPharmacologyPhenotypePhysiologic OssificationPopulationPrevalenceReporterRisk FactorsRoleSkeletonSynovial MembraneTestingTissuesTransgenic OrganismsTubeVascular Endothelial CellWorkage relatedangiogenesisarthropathiesarticular cartilagebonebone cellcell typedefined contributiondriving forceepidemiology studyfrailtyfunctional lossgenetic approachjoint destructionjoint injurymetabolic phenotypemouse modelnovelosteoarthritis painoverexpressionplatelet-derived growth factor BBradiological imagingsenescencesubchondral bonetreatment strategy
项目摘要
SUMMARY/ABSTRACT
Osteoarthritis (OA) is the most prevalent age-associated chronic joint disease. Although direct joint injury and
excessive mechanical overloading are considered as important contributors to the development of OA, only
approximately 12% of the overall prevalence of symptomatic OA is attributable to posttraumatic OA of the hip,
knee, or ankle. Aging is recognized as the most important risk factor for OA, and the metabolic phenotype
becomes the second most frequent subtype of OA among patients enrolled in clinical studies. Recently, it has
been recognized that cellular senescence is a key driver for the progression of post-traumatic OA. However,
whether and how senescent cells (SnCs) are involved in the development of non-traumatic OA remain poorly
understood. In our preliminary study, we found accumulated SnCs at the joint subchondral bone marrow of both
spontaneous aging OA mice and STR/Ort mice, a spontaneous OA mice associated with metabolic dysregulation.
Increased SnCs were not detected in subchondral bone marrow of a post-traumatic OA mice. Therefore,
subchondral bone marrow cell senescence may represent a unique feature of non-traumatic subtype of OA
distinguishable from post-traumatic OA. Moreover, we identified that close to 80% of the SnCs are bone marrow
Pre-osteoclast (Pre-OC). Pre-OCs isolated from old mice, relative to young mice, had increased expression of
common senescence-associated secretory phenotype (SASP) factors and much higher expression of
angiogenesis factor PDGF-BB, a potent angiogenesis factor. It is known that increased subchondral bone
angiogenesis is a major contributor to the development of OA. Therefore, the excessive PDGF-BB secreted by
subchondral bone marrow SnCs may contribute to aberrant subchondral bone angiogenesis. Our central
hypothesis is that senescent Pre-OCs induce aberrant subchondral bone angiogenesis by secreting excessive
PDGF-BB, leading to OA-related joint structural damage. The hypothesis will be tested by the following Specific
Aims. In Aim 1, we will trace the SnCs in synovial tissue, articular cartilage, and subchondral bone tissue of the
joints by detecting the cellular senescence markers in spontaneous aging OA mice and STR/Ort mice. We will
also trace the SnCs at different stages of OC lineage and verify the SASP phenotype of the cells in bone marrow
of the mice. Aim 2 will examine the necessity and sufficiency of Pre-OCs-derived PDGF-BB in age-associated
subchondral bone angiogenesis and OA development. In Aim 3, we will first define the contribution of cellular
senescence to subchondral bone angiogenesis and osteogenesis by selectively eliminating the SnCs in OA mice.
We will then test if blockage of Pre-OC senescence using both genetic and pharmacologic approaches
attenuates OA progression.
摘要/摘要
骨关节炎(OA)是最常见的与年龄相关的慢性关节疾病。虽然直接关节损伤和
过度的机械超载被认为是 OA 发展的重要因素,只有
大约 12% 的症状性 OA 总体患病率可归因于髋部创伤后 OA,
膝盖或脚踝。衰老被认为是 OA 最重要的危险因素,代谢表型
成为参加临床研究的患者中第二常见的 OA 亚型。近日,有
人们认识到细胞衰老是创伤后骨关节炎进展的关键驱动因素。然而,
衰老细胞 (SnC) 是否以及如何参与非创伤性 OA 的发展仍不清楚
明白了。在我们的初步研究中,我们发现在两者的关节软骨下骨髓中积累了 SnC。
自发性衰老 OA 小鼠和 STR/Ort 小鼠,自发性 OA 小鼠与代谢失调相关。
在创伤后 OA 小鼠的软骨下骨髓中未检测到 SnC 增加。所以,
软骨下骨髓细胞衰老可能代表非创伤性 OA 亚型的独特特征
与创伤后 OA 不同。此外,我们发现接近 80% 的 SnC 是骨髓
破骨细胞前体(Pre-OC)。与年轻小鼠相比,从老年小鼠中分离出的前 OCs 的表达增加
常见的衰老相关分泌表型(SASP)因子和更高的表达
血管生成因子PDGF-BB,一种有效的血管生成因子。众所周知,软骨下骨增加
血管生成是 OA 发展的主要贡献者。因此,分泌过多的PDGF-BB
软骨下骨髓 SnCs 可能导致异常软骨下骨血管生成。我们的中央
假设衰老的 Pre-OCs 通过分泌过多的脂质来诱导异常的软骨下骨血管生成
PDGF-BB,导致骨关节炎相关的关节结构损伤。该假设将通过以下具体内容进行检验
目标。在目标 1 中,我们将追踪滑膜组织、关节软骨和软骨下骨组织中的 SnC。
通过检测自发衰老 OA 小鼠和 STR/Ort 小鼠的细胞衰老标记物来研究关节。我们将
还追踪 OC 谱系不同阶段的 SnC,并验证骨髓中细胞的 SASP 表型
老鼠的。目标 2 将检验 Pre-OCs 衍生的 PDGF-BB 在与年龄相关的疾病中的必要性和充分性
软骨下骨血管生成和 OA 发展。在目标 3 中,我们将首先定义细胞的贡献
通过选择性消除 OA 小鼠中的 SnCs 来影响软骨下骨血管生成和骨生成的衰老。
然后,我们将测试是否使用遗传和药理学方法来阻断 Pre-OC 衰老
减缓 OA 的进展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mei Wan其他文献
Mei Wan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mei Wan', 18)}}的其他基金
Senescence of Pre-Osteoclasts in Non-Traumatic OA
非创伤性骨关节炎中前破骨细胞的衰老
- 批准号:
10090198 - 财政年份:2021
- 资助金额:
$ 35.23万 - 项目类别:
Identifying A Skeleton-Derived Factor for Vascular Aging
识别血管老化的骨骼衍生因子
- 批准号:
10544756 - 财政年份:2021
- 资助金额:
$ 35.23万 - 项目类别:
Identifying A Skeleton-Derived Factor for Vascular Aging
识别血管老化的骨骼衍生因子
- 批准号:
10380873 - 财政年份:2021
- 资助金额:
$ 35.23万 - 项目类别:
Identifying A Skeleton-Derived Factor for Vascular Aging
识别血管老化的骨骼衍生因子
- 批准号:
10202909 - 财政年份:2021
- 资助金额:
$ 35.23万 - 项目类别:
Senescence of Pre-Osteoclasts in Non-Traumatic OA
非创伤性骨关节炎中前破骨细胞的衰老
- 批准号:
10556420 - 财政年份:2021
- 资助金额:
$ 35.23万 - 项目类别:
Role of Cellular Senescence in the Bone-Brain Interplay
细胞衰老在骨脑相互作用中的作用
- 批准号:
10417206 - 财政年份:2020
- 资助金额:
$ 35.23万 - 项目类别:
Role of Cellular Senescence in the Bone-Brain Interplay
细胞衰老在骨脑相互作用中的作用
- 批准号:
10634546 - 财政年份:2020
- 资助金额:
$ 35.23万 - 项目类别:
Targeting aging genes and pathways to promote optic nerve regeneration
针对衰老基因和途径促进视神经再生
- 批准号:
10547815 - 财政年份:2020
- 资助金额:
$ 35.23万 - 项目类别:
Targeting aging genes and pathways to promote optic nerve regeneration
针对衰老基因和途径促进视神经再生
- 批准号:
10326837 - 财政年份:2020
- 资助金额:
$ 35.23万 - 项目类别:
Role of Cellular Senescence in the Bone-Brain Interplay
细胞衰老在骨脑相互作用中的作用
- 批准号:
10041954 - 财政年份:2020
- 资助金额:
$ 35.23万 - 项目类别:
相似国自然基金
TBX20在致盲性老化相关疾病年龄相关性黄斑变性中的作用和机制研究
- 批准号:82220108016
- 批准年份:2022
- 资助金额:252 万元
- 项目类别:国际(地区)合作与交流项目
LncRNA ALB调控LC3B活化及自噬在体外再生晶状体老化及年龄相关性白内障发病中的作用及机制研究
- 批准号:81800806
- 批准年份:2018
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
APE1调控晶状体上皮细胞老化在年龄相关性白内障发病中的作用及机制研究
- 批准号:81700824
- 批准年份:2017
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
KDM4A调控平滑肌细胞自噬在年龄相关性血管老化中的作用及机制
- 批准号:81670269
- 批准年份:2016
- 资助金额:55.0 万元
- 项目类别:面上项目
老年人一体化编码的认知神经机制探索与干预研究:一种减少与老化相关的联结记忆缺陷的新途径
- 批准号:31470998
- 批准年份:2014
- 资助金额:87.0 万元
- 项目类别:面上项目
相似海外基金
The Influence of Lifetime Occupational Experience on Cognitive Trajectories Among Mexican Older Adults
终生职业经历对墨西哥老年人认知轨迹的影响
- 批准号:
10748606 - 财政年份:2024
- 资助金额:
$ 35.23万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 35.23万 - 项目类别:
Understanding the Mechanisms and Consequences of Basement Membrane Aging in Vivo
了解体内基底膜老化的机制和后果
- 批准号:
10465010 - 财政年份:2023
- 资助金额:
$ 35.23万 - 项目类别:
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
- 批准号:
10462257 - 财政年份:2023
- 资助金额:
$ 35.23万 - 项目类别:
Project 3: 3-D Molecular Atlas of cerebral amyloid angiopathy in the aging brain with and without co-pathology
项目 3:有或没有共同病理的衰老大脑中脑淀粉样血管病的 3-D 分子图谱
- 批准号:
10555899 - 财政年份:2023
- 资助金额:
$ 35.23万 - 项目类别: